LLS symposium to review latest advances in blood cancer research

Targeted therapies and personalized medicine for patients with hematologic malignancies

LLS Research Symposium: "Targeted Therapies & Personalized Medicine" for Patients with Hematologic Malignancies

What: A cadre of leading researchers in hematology, oncology, cell biology, and biotechnology are conducting presentations and discussions at this symposium to review the latest advances in blood cancer research, including:

• Ron Levy, MD, Stanford (9:15 a.m.)
• Anthony G. Letai, MD, PhD, Dana-Farber Cancer Institute (10 a.m.)
• Monica L. Guzman, PhD, Weill Cornell Medical College (9:30 a.m.)
• Stephan A. Grupp, MD, PhD, Children's Hospital of Philadelphia (3:30 p.m.)
• Larry W. Kwak, MD, PhD, MD Anderson Cancer Center (4 p.m.)
• G. Steven Burrill, "biotech guru" (Keynote speaker and panelist) (1 p.m.)
• Thomas O. Daniel, MD, Celgene (1 p.m. panel discussion)

Where: 5th Floor of the Westin New York (270 West 43rd Street)

When: Thursday October 18, 2012, 9 a.m. to 5 p.m.